Susquehanna International Group, LLP Moon Lake Immunotherapeutics Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$40.15 - $55.4 $1.23 Million - $1.7 Million	-30,700 Reduced 69.14%	13,700 $690,000
Q2 2024 Aug 15, 2024	SELL	$38.43 - $48.6 $3.13 Million - $3.96 Million	-81,500 Reduced 64.73%	44,400 $1.95 Million
Q1 2024 May 07, 2024	BUY	$43.78 - $63.86 $1.68 Million - $2.45 Million	38,300 Added 43.72%	125,900 $6.32 Million
Q4 2023 Feb 14, 2024	SELL	$36.35 - $63.02 $977,815 - $1.7 Million	-26,900 Reduced 23.49%	87,600 $5.29 Million
Q3 2023 Nov 14, 2023	BUY	$48.35 - $61.26 $5.54 Million - $7.01 Million	114,500 New	114,500 $6.53 Million

124

58.2M

52.2K

38K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $1.92B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.